CD36 and breast cancer: Similarly, our results demonstrated that adipocyte-released metabolic intermediates are transferred to breast cancer cells, which increased fatty acid uptake by overexpressing CD36 and FATP1 and accelerated FAO through the AMPK/ACC2/CPT1α axis, as previously reported [43, 48].